Compare RANI & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | FTLF |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.7M | 154.6M |
| IPO Year | 2021 | N/A |
| Metric | RANI | FTLF |
|---|---|---|
| Price | $1.40 | $16.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $8.67 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 1.4M | 16.4K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | $1,200,000.00 | ★ $70,561,000.00 |
| Revenue This Year | $414.59 | $32.74 |
| Revenue Next Year | $30.15 | $50.36 |
| P/E Ratio | ★ N/A | $24.43 |
| Revenue Growth | N/A | ★ 12.44 |
| 52 Week Low | $0.39 | $9.83 |
| 52 Week High | $3.87 | $20.98 |
| Indicator | RANI | FTLF |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 50.75 |
| Support Level | $1.31 | $15.01 |
| Resistance Level | $1.44 | $16.68 |
| Average True Range (ATR) | 0.08 | 0.60 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 43.14 | 73.54 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.